AI assistant
Sending…
PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2017
Feb 2, 2017
33488_dirs_2017-02-02_7a54519c-b753-4dc8-8d87-2e38b174e21d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2017-02-01
Reporting Person: CHARNAS ROBERT (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-01 | COMMON STOCK | S | 1000 | $31.80 | Disposed | 28461 | Direct |
| 2017-02-01 | COMMON STOCK | S | 2008 | $31.85 | Disposed | 26453 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016.
More from PUMA BIOTECHNOLOGY, INC.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8